BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26778104)

  • 1. Viral metagenomics and blood safety.
    Sauvage V; Eloit M
    Transfus Clin Biol; 2016 Feb; 23(1):28-38. PubMed ID: 26778104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of viral metagenomics in blood transfusion safety.
    Sauvage V; Gomez J; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):218-222. PubMed ID: 28694025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections.
    Sauvage V; Laperche S; Cheval J; Muth E; Dubois M; Boizeau L; Hébert C; Lionnet F; Lefrère JJ; Eloit M
    Blood Transfus; 2016 Sep; 14(5):400-7. PubMed ID: 27136432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New viral risks in blood transfusion by 2016].
    Pozzetto B; Garraud O
    Transfus Clin Biol; 2016 Feb; 23(1):20-7. PubMed ID: 26781857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Emergent viral threats in blood transfusion].
    Pozzetto B; Garraud O
    Transfus Clin Biol; 2011 Apr; 18(2):174-83. PubMed ID: 21414828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Metagenomics for Identification of Emerging Viruses in Transfusion Medicine.
    Slavov SN
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral metagenomics in Brazilian multiply transfused patients with sickle cell disease as an indicator for blood transfusion safety.
    Nunes Valença I; Silva-Pinto AC; Araújo da Silva Júnior W; Tadeu Covas D; Kashima S; Nanev Slavov S
    Transfus Clin Biol; 2020 Nov; 27(4):237-242. PubMed ID: 32758666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya].
    Paty MC
    Transfus Clin Biol; 2013 May; 20(2):165-73. PubMed ID: 23622840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relevance of safety measures to avoid HTLV transmission by transfusion in 2014].
    Laperche S; Pillonel J
    Transfus Clin Biol; 2014 Nov; 21(4-5):167-72. PubMed ID: 25267203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Orthopoxviruses: infections in humans. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):957-72. PubMed ID: 20853093
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging viruses and transfusion.
    Allain JP
    Transfus Clin Biol; 2001 Jun; 8(3):220-1. PubMed ID: 11499963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viruses and unconventional transmissible agents: update on transmission via blood ].
    Barin F
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():5s-10s. PubMed ID: 10919217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep sequencing applied to the analysis of viromes in patients with beta-thalassemia.
    Valença IN; Santos RBD; Peronni KC; Sauvage V; Vandenbogaert M; Caro V; Silva Junior WAD; Covas DT; Silva-Pinto AC; Laperche S; Kashima S; Slavov SN
    Rev Inst Med Trop Sao Paulo; 2021; 63():e40. PubMed ID: 34037156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technological evolutions in blood donation screening and their impact on the residual risk].
    Barlet V
    Transfus Clin Biol; 2011 Apr; 18(2):292-301. PubMed ID: 21466969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
    Butler EK; McCullough J
    Transfusion; 2018 Apr; 58(4):854-861. PubMed ID: 29405306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of a transfusion emergent risk: the case of HEV].
    Pillonel J; Gallian P; Sommen C; Couturier E; Piquet Y; Djoudi R; Laperche S;
    Transfus Clin Biol; 2014 Nov; 21(4-5):162-6. PubMed ID: 25267205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to minimize infection risk in blood banking and transfusion practice.
    Lindholm PF; Annen K; Ramsey G
    Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.